Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.900
+0.230 (13.77%)
At close: Dec 16, 2025, 4:00 PM EST
1.740
-0.160 (-8.42%)
After-hours: Dec 16, 2025, 4:52 PM EST
Adagene Market Cap
Adagene has a market cap or net worth of $89.55 million as of December 16, 2025. Its market cap has decreased by -12.43% in one year.
Market Cap
89.55M
Enterprise Value
28.86M
1-Year Change
-12.43%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $89.55M, a decrease of -88.87%. That is a compound annual growth rate of -36.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 78.71M | -10.66% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | 804.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |